Accelerate Diagnostics, Inc
AXDXDelisted Jul 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000727207
Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Accelerate Diagnostics, Inc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
AXDX is no longer listed, so this page shows Q1 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 43
- −3 vs. Q4 2024
- Shares held
- 4.43M
- −286.3K (−6.1%) vs. Q4 2024
- Total value
- $3.10M
- −$2.58M (−45.4%) vs. Q4 2024
- New holders
- 4
- 6 more added
- Sold out
- 7
- 12 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 3 | $2.08K |
| Q1 2025 | 43 | $3.10M |
| Q4 2024 | 47 | $5.69M |
| Q3 2024 | 46 | $8.20M |
| Q2 2024 | 41 | $4.98M |
| Q1 2024 | 46 | $4.55M |
| Q4 2023 | 43 | $9.78M |
| Q3 2023 | 38 | $14.7M |
| Q2 2023 | 51 | $18.0M |
| Q1 2023 | 67 | $17.2M |
| Q4 2022 | 73 | $18.0M |
| Q3 2022 | 84 | $41.2M |
| Q2 2022 | 75 | $18.6M |
| Q1 2022 | 106 | $33.1M |
| Q4 2021 | 107 | $124.7M |
| Q3 2021 | 105 | $138.2M |
| Q2 2021 | 95 | $194.7M |
| Q1 2021 | 99 | $205.1M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Accelerate Diagnostics, Inc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,879,227 | $1.32M | 0.04% | −198,773−9.6% | Reduced |
| Griffin Asset Management, Inc. | 853,036 | $598.0K | 0.07% | −150,545−15.0% | Reduced |
| Vanguard Group Inc | 478,093 | $335.1K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 325,239 | $228.0K | 0.20% | 00.0% | Unchanged |
| Lido Advisors, LLC | 163,161 | $114.4K | 0.00% | +163,161 | New |
| Geode Capital Management, LLC | 142,518 | $99.9K | 0.00% | +6,786+5.0% | Added |
| Spears Abacus Advisors LLC | 114,523 | $80.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 64,200 | $45.0K | 0.00% | −42,862−40.0% | Reduced |
| TCI Wealth Advisors, Inc. | 55,586 | $39.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 55,268 | $38.7K | 0.00% | +25,616+86.4% | Added |
| BlackRock, Inc. | 50,842 | $35.6K | 0.00% | 00.0% | Unchanged |
| Cladis Investment Advisory, LLC | 42,700 | $29.9K | 0.02% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 33,820 | $23.7K | 0.00% | −121−0.4% | Reduced |
| Citadel Advisors LLC | 23,451 | $16.4K | 0.00% | −11,961−33.8% | Reduced |
| State Street Corp | 20,415 | $14.3K | 0.00% | 00.0% | Unchanged |
| Ironwood Financial, llc | 20,313 | $14.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 18,395 | $12.9K | 0.00% | +1,459+8.6% | Added |
| Northern Trust Corp | 16,953 | $11.9K | 0.00% | −13,070−43.5% | Reduced |
| Tudor Investment Corp Et Al | 14,110 | $9.89K | 0.00% | 00.0% | Unchanged |
| Tejara Capital Ltd | 13,056 | $9.15K | 0.00% | −84−0.6% | Reduced |
| Wells Fargo & Company | 10,489 | $7.35K | 0.00% | +10,450+26,794.9% | Added |
| Thompson Investment Management, Inc. | 10,390 | $7.28K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 10,400 | $5.67K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 3,939 | $2.29K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,930 | $2.05K | 0.00% | −2,655−47.5% | Reduced |
| Bank of America Corp | 2,131 | $1.49K | 0.00% | −24−1.1% | Reduced |
| Simplex Trading, LLC | 1,905 | $1.00K | 0.00% | +542+39.8% | Added |
| SRS Capital Advisors, Inc. | 1,000 | $701 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 956 | $670 | 0.00% | −1−0.1% | Reduced |
| Advisor Group Holdings, Inc. | 889 | $622 | 0.00% | +889 | New |
| BNP Paribas Arbitrage, SA | 310 | $217 | 0.00% | −47−13.2% | Reduced |
| Albion Financial Group | 212 | $149 | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 160 | $112 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 160 | $112 | 0.00% | 00.0% | Unchanged |
| Tower Trust & Investment Co | 140 | $72 | 0.00% | +140 | New |
| GHP Investment Advisors, Inc. | 100 | $71 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 100 | $70 | 0.00% | 00.0% | Unchanged |
| Bartlett & Co. Wealth Management LLC | 100 | $70 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 36 | $26 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 32 | $23 | 0.00% | +1+3.2% | Added |
| UBS Group AG | 20 | $14 | 0.00% | −20−50.0% | Reduced |
| SBI Securities Co., Ltd. | 3 | $2 | 0.00% | +3 | New |
| CWM, LLC | 219 | $0 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −22,415−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,930−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,214−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −10,678−100.0% | Sold out |
| Stratos Wealth Partners, LTD. | 0 | $0 | 0.00% | −10,628−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −4,776−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −527−100.0% | Sold out |
| Northwest Bank & Trust Co | – | – | – | – | Not filed |